So you are saying Drs are doing internal statistics on blinded data from their own hospitals and making unscientific and statistically invalid guesses for their patients treatment? The most numbers at any sight, we know publicly, is that UCLA had about 30 - vary small number to make any statistical conclusions. The Drs are trained in stats and I don't think they would be thinking as layman like that. It would also be completely unethical for them to advise patients like that based on their unscientific guesswork.
Can you point out where you have evidence that MSB was aware of blinded death rates?
Novartis deal on the rocks, page-104
-
- There are more pages in this discussion • 144 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.030(2.52%) |
Mkt cap ! $1.324B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $5.184M | 4.406M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 194493 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 49214 | 12 |
View Market Depth
| Last trade - 15.17pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |